393 related articles for article (PubMed ID: 33242493)
1. Enrichment of circulating tumor-derived extracellular vesicles from human plasma.
Yoh KE; Lowe CJ; Mahajan S; Suttmann R; Nguy T; Reichelt M; Yang J; Melendez R; Li Y; Molinero L; Ruppel J; Xu W; Plaks V
J Immunol Methods; 2021 Mar; 490():112936. PubMed ID: 33242493
[TBL] [Abstract][Full Text] [Related]
2. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.
Serratì S; Guida M; Di Fonte R; De Summa S; Strippoli S; Iacobazzi RM; Quarta A; De Risi I; Guida G; Paradiso A; Porcelli L; Azzariti A
Mol Cancer; 2022 Jan; 21(1):20. PubMed ID: 35042524
[TBL] [Abstract][Full Text] [Related]
3. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
[TBL] [Abstract][Full Text] [Related]
4. Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1.
Lee CH; Bae JH; Choe EJ; Park JM; Park SS; Cho HJ; Song BJ; Baek MC
Theranostics; 2022; 12(5):1971-1987. PubMed ID: 35265193
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment.
Nanou A; Zeune LL; Terstappen LWMM
Cells; 2019 Aug; 8(8):. PubMed ID: 31434250
[TBL] [Abstract][Full Text] [Related]
7. Rapid Evaluation of Lung Adenocarcinoma Progression by Detecting Plasma Extracellular Vesicles with Lateral Flow Immunoassays.
Lu C; Xiao W; Su Y; Zhang X; Chen Y; Lu K; Teng P; Liang J; Yang H; Song Q; Tang Y; Cao D
ACS Sens; 2023 May; 8(5):1950-1959. PubMed ID: 37195005
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.
Eslami-S Z; Cortés-Hernández LE; Sinoquet L; Gauthier L; Vautrot V; Cayrefourcq L; Avoscan L; Jacot W; Pouderoux S; Viala M; Thomas QD; Lamy PJ; Quantin X; Gobbo J; Alix-Panabières C
Br J Cancer; 2024 Jan; 130(1):63-72. PubMed ID: 37973956
[TBL] [Abstract][Full Text] [Related]
9. Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
Signorelli D; Ghidotti P; Proto C; Brambilla M; De Toma A; Ferrara R; Galli G; Ganzinelli M; Lo Russo G; Prelaj A; Occhipinti M; Viscardi G; Capizzuto V; Pontis F; Petraroia I; Ferretti AM; Colombo MP; Torri V; Sozzi G; Garassino MC; Jachetti E; Fortunato O
Front Immunol; 2022; 13():987639. PubMed ID: 36203609
[TBL] [Abstract][Full Text] [Related]
10. Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
de Miguel-Perez D; Russo A; Gunasekaran M; Buemi F; Hester L; Fan X; Carter-Cooper BA; Lapidus RG; Peleg A; Arroyo-Hernández M; Cardona AF; Naing A; Hirsch FR; Mack PC; Kaushal S; Serrano MJ; Adamo V; Arrieta O; Rolfo C
Cancer; 2023 Feb; 129(4):521-530. PubMed ID: 36484171
[TBL] [Abstract][Full Text] [Related]
11. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.
de Miguel-Perez D; Russo A; Arrieta O; Ak M; Barron F; Gunasekaran M; Mamindla P; Lara-Mejia L; Peterson CB; Er ME; Peddagangireddy V; Buemi F; Cooper B; Manca P; Lapidus RG; Hsia RC; Cardona AF; Naing A; Kaushal S; Hirsch FR; Mack PC; Serrano MJ; Adamo V; Colen RR; Rolfo C
J Exp Clin Cancer Res; 2022 Jun; 41(1):186. PubMed ID: 35650597
[TBL] [Abstract][Full Text] [Related]
13. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
[TBL] [Abstract][Full Text] [Related]
14. Isolation and analysis of tumor‑derived extracellular vesicles from head and neck squamous cell carcinoma plasma by galectin‑based glycan recognition particles.
Benecke L; Chiang DM; Ebnoether E; Pfaffl MW; Muller L
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36129151
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 detection on circulating tumor-derived extracellular vesicles (T-EVs) from patients with lung cancer.
Wu F; Gu Y; Kang B; Heskia F; Pachot A; Bonneville M; Wei P; Liang J
Transl Lung Cancer Res; 2021 Jun; 10(6):2441-2451. PubMed ID: 34295653
[TBL] [Abstract][Full Text] [Related]
16. Delivery of miR-424-5p via Extracellular Vesicles Promotes the Apoptosis of MDA-MB-231 TNBC Cells in the Tumor Microenvironment.
Zhou Y; Yamamoto Y; Takeshita F; Yamamoto T; Xiao Z; Ochiya T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467725
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer.
Dou X; Hua Y; Chen Z; Chao F; Li M
Clin Exp Immunol; 2022 May; 207(3):307-317. PubMed ID: 35553630
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients.
Hur JY; Kim HJ; Lee JS; Choi CM; Lee JC; Jung MK; Pack CG; Lee KY
Mol Cancer; 2018 Jan; 17(1):15. PubMed ID: 29374476
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles released by non-small cell lung cancer cells drive invasion and permeability in non-tumorigenic lung epithelial cells.
Hasan H; Sohal IS; Soto-Vargas Z; Byappanahalli AM; Humphrey SE; Kubo H; Kitdumrongthum S; Copeland S; Tian F; Chairoungdua A; Kasinski AL
Sci Rep; 2022 Jan; 12(1):972. PubMed ID: 35046472
[TBL] [Abstract][Full Text] [Related]
20. A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma.
Campos-Silva C; Cáceres-Martell Y; Sánchez-Herrero E; Sandúa A; Beneitez-Martínez A; González Á; Provencio M; Romero A; Jara-Acevedo R; Yáñez-Mó M; Valés-Gómez M
J Nanobiotechnology; 2022 Feb; 20(1):72. PubMed ID: 35135541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
